A comparison study of conventional chemoradiotherapy plus cetuximab (CTX) or nimotuzumab (NTZ) to CRT alone in stage II-IV Nasopharyngeal cancer patients
Latest Information Update: 18 Aug 2020
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin (Primary) ; Nimotuzumab (Primary)
- Indications Nasopharyngeal cancer
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 18 Aug 2020 New trial record